×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRVO – cervomed inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
08:28 am
crvo
CervoMed (CRVO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $15.00 price target on the stock.
Low
Report
CervoMed (CRVO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $15.00 price target on the stock.
3/5
07:30 am
crvo
CervoMed to Participate in Upcoming Investor Conferences
Low
Report
CervoMed to Participate in Upcoming Investor Conferences
3/4
02:49 pm
crvo
CervoMed (CRVO) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $31.00 price target on the stock.
Low
Report
CervoMed (CRVO) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $31.00 price target on the stock.
3/4
07:30 am
crvo
CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies
Medium
Report
CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies
2/18
08:13 am
crvo
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
Medium
Report
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
2/18
06:00 am
crvo
CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
Medium
Report
CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
2/6
05:33 pm
crvo
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Medium
Report
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
2/5
06:09 am
crvo
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Medium
Report
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/4
04:07 pm
crvo
Form 8-K CervoMed Inc. For: Mar 04
Low
Report
Form 8-K CervoMed Inc. For: Mar 04
2/18
04:25 pm
crvo
Form 8-K CervoMed Inc. For: Feb 18
High
Report
Form 8-K CervoMed Inc. For: Feb 18
2/13
05:03 pm
crvo
Form 4 CervoMed Inc. For: Feb 11 Filed by: Winton Matthew
Medium
Report
Form 4 CervoMed Inc. For: Feb 11 Filed by: Winton Matthew
2/13
05:02 pm
crvo
Form 4 CervoMed Inc. For: Feb 11 Filed by: Gregoire Sylvie
Medium
Report
Form 4 CervoMed Inc. For: Feb 11 Filed by: Gregoire Sylvie
2/13
05:02 pm
crvo
Form 4 CervoMed Inc. For: Feb 11 Filed by: ELDER WILLIAM ROBERT
Medium
Report
Form 4 CervoMed Inc. For: Feb 11 Filed by: ELDER WILLIAM ROBERT
2/13
05:01 pm
crvo
Form 4 CervoMed Inc. For: Feb 11 Filed by: ALAM JOHN J
Medium
Report
Form 4 CervoMed Inc. For: Feb 11 Filed by: ALAM JOHN J
2/13
05:01 pm
crvo
Form 4 CervoMed Inc. For: Feb 11 Filed by: De Rosch Mark
Medium
Report
Form 4 CervoMed Inc. For: Feb 11 Filed by: De Rosch Mark
2/13
05:01 pm
crvo
Form 4 CervoMed Inc. For: Feb 11 Filed by: Blackburn Kelly
Medium
Report
Form 4 CervoMed Inc. For: Feb 11 Filed by: Blackburn Kelly
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: